World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03190005
Date of registration: 06/06/2017
Prospective Registration: No
Primary sponsor: Taipei City Hospital
Public title: Downstream Molecular Signals of P2Y12 Receptors in Hyporeactive Patients Under Clopidogrel Treatment A Possible Mechanism of HOTPR(High On-Treatment Platelet Reactivity)
Scientific title: Downstream Molecular Signals of P2Y12 Receptors in Hyporeactive Patients Under Clopidogrel Treatment (A Possible Mechanism of HOTPR:High On- Treatment Platelet Reactivity)
Date of first enrolment: January 1, 2017
Target sample size: 35
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03190005
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Taiwan
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- DAPT(Dual antiplatelet therapy) after regular stent implantation.

Exclusion Criteria:

- allergy to DAPT(Dual antiplatelet therapy). major bleeding intolerance to DAPT(Dual
antiplatelet therapy).



Age minimum: 18 Years
Age maximum: 99 Years
Gender: All
Health Condition(s) or Problem(s) studied
Stable Angina
Intervention(s)
Drug: clopidogrel
Drug: Placebos
Primary Outcome(s)
PRU(Platelet Rreactivity Unit) 24 Hours After DAPT(Dual AntiPlatelet Therapy) Western Blot After Medication [Time Frame: 24 hours]
Secondary Outcome(s)
Secondary ID(s)
TCHIRB-10603117-E
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available: Yes
Date Posted: 21/11/2019
Date Completed:
URL: https://clinicaltrials.gov/ct2/show/results/NCT03190005
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history